secwatch / observer
8-K filed July 3, 2023, 7:59 PM ET ticker ADPT CIK 0001478320
regulatory confidence high sentiment negative materiality 0.50

Adaptive Biotechnologies Corp (ADPT): Nasdaq/NYSE listing notice — Adaptive Biotechnologies receives Nasdaq notice for Audit Committee non-compliance after director resignation

Adaptive Biotechnologies Corp

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Adaptive Biotechnologies Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
audit committee
Rules
5605(c)(2)(A)
Exact text from the filing
June 26, 2023, the Company received a notice from Nasdaq regarding non-compliance with the rule requiring three members to serve on an Audit Committee and confirming the cure period applicable to the Company. The Company is evaluating the appropriate composition of its board committees and fully intends to regain compliance with Rule 5605(c)(2)(A) within the applicable cure period. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Adaptive Biotechnol
View on SEC.gov

Browse all listing & compliance notices →

Adaptive Biotechnologies Corp filing history →

Source: SEC EDGAR
accession 0001193125-23-181293
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.